Peer Review channel feed

One year in, Joanne Kotz as­sumes CEO role at Jnana; Pres­i­dent/Ex­ec­u­tive chair duo will now run Black­Thorn

7 years ago

Sun Bio­Phar­ma founder Michael Cullen steps up; Se­maThera set­tles on per­ma­nent CEO; On­coSec nabs Kel­lie Mal­loy Fo­ert­er from Sy­neos

7 years ago

Long­time Api­tope CEO Kei­th Mar­tin steps down; Clear­side Bio­med­ical taps Spark ex­ec as CMO

7 years ago

Medi­vir taps ex-Aca­dia chief Uli Hack­sell as in­ter­im CEO; Mer­ck on­boards chief dig­i­tal of­fi­cer

7 years ago

Per­ri­go taps ex-to­bac­co ex­ec as new CEO; Dana Far­ber T cell in­ves­ti­ga­tor Nick Hain­ing joins Mer­ck

7 years ago

Bel­gian up­start Rewind taps Ian Reynolds as CEO; Robert Fos­ter takes the reins at Con­traVir

7 years ago

Ian Read taps his care­ful­ly groomed suc­ces­sor Al­bert Bourla as the next Pfiz­er CEO. What's his fu­ture look like?

7 years ago
People

Fred Aslan re­turns to biotech as pres­i­dent of Vi­vid­ion; Zai Lab scoops Por­to­la's Tao Fu to spear­head US op­er­a­tions

7 years ago

Ex-Cas­ca­di­an chief Scott My­ers lands at Bio­Clin; Ko­di­ak woos Genen­tech vet Ja­son Ehrlich for CMO role

7 years ago

Top sci­en­tist Thor Voigt vaults to CMO role at Boehringer In­gel­heim; Cel­gene's Scott Smith tapped as pres­i­dent at BioAt­la

7 years ago

Ovid ex­ec Yaron Wer­ber cross­es back to Cowen; Saqib Is­lam pro­mot­ed to Spring­Work­s' first CEO slot

7 years ago

Ed­i­tas CMO to ex­it as CRISPR tech gears up; Roche di­ag­nos­tics di­vi­sion CEO Roland Diggel­mann is out

7 years ago

E-Scape Bio in­stalls per­ma­nent CEO Julie Anne Smith; Fa­ther pass­es reins to son at Al­le­gro Oph­thalmics

7 years ago

John Kaiser finds next CEO role at Duke spin­out Evecx­ia; Im­muno­core vet Namir Has­san moves to I/O biotech Zel­lu­na

7 years ago

Mer­ck vet Thomas Can­nell takes the reins at Sesen Bio; Post-tur­bu­lence, Rock­well Med­ical ap­points new CEO

7 years ago

Cell Med­ica scoops Kite Phar­ma's Chris Now­ers as CEO; Shire vet jumps to Edi­Gene as CEO

7 years ago

Af­ter huge mega-round, CStone poach­es Gold­man's Richard Yeh as CFO; Both Hoop­er and Harp­er ex­it Am­gen's re­volv­ing door

7 years ago

An­tho­ny Quinn ce­ments Ae­glea CEO spot; Hu­man Longevi­ty bumps David Karow up to the top

7 years ago

George Golumbeski's first stop out of Cel­gene: Grail; Roivant taps Genen­tech vet Myr­tle Pot­ter for op­er­a­tions role

7 years ago

Ac­celeron poach­es ex-Abl­ynx CMO Robert Zeldin; Deb­o­rah Dun­sire leaves for Lund­beck­'s top job af­ter XTu­it im­plo­sion

7 years ago

An­drew Rit­ter gath­ers the reins as his com­pa­ny preps PhI­II; Sol­id Bio co-founder Gi­lad Hay­eem re­tires

7 years ago

In high-lev­el reshuf­fle, Roche gives James Sabry the glob­al reins on deal-mak­ing — over­see­ing pRED and gRED

7 years ago
People

Aim­mune signs Jayson Dal­las on to suc­ceed re­tir­ing CEO; Ed­uar­do Bra­vo leaves TiGenix in fi­nal chap­ter of Take­da buy­out

7 years ago

Ru­bius snaps up No­var­tis vet Pablo Cagnoni as CEO; MiMedx dumps two ex­ecs fol­low­ing in­ter­nal in­ves­ti­ga­tion

7 years ago
First page Previous page 12131415161718 Next page Last page
A service from the Financial Times